📷 Image: Wikimedia Commons / The U.S. Food and Drug Administration
Health
FDA Approves Tylenol Combination
✍️ Asianet Newsable
🗓 25 Jul 2026, 07:33 AM
👁 34
The FDA has approved a Tylenol combination despite pushback from the Trump administration. This move has led to a rise in KVUE stock.
The US Food and Drug Administration (FDA) has given its approval to a combination of Tylenol, a widely used pain reliever. This decision comes despite opposition from the Trump administration. As a result, the stock price of KVUE has seen a significant increase. The FDA's approval is a crucial step for any new medication or combination to enter the market. The Trump administration's pushback had raised concerns about the approval process, but the FDA has ultimately given its nod to the Tylenol combination.